Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Wednesday, October 7, 2026

Can AI help discover new quality measures for oncology?

›
In some circles, you hear that we need new better quality measures in oncology, but it's not always clear how to go about discovering th...

CMS Wants Your Views on its Fraud Contractors (UPICs etc)

›
Earlier this year, CMS posted an RFI on its "CRUSH" anti fraud scale-up.  CMS has generated a proposed rule now percolating at OMB...
Monday, October 5, 2026

PAMA: What Happened to Exome, Genome, and NIPT?

›
 Under PAMA, what happens to Exome, Genome, and NIPT beginning in 2027? Here's the data, click to enlarge: click to enlarge Exome 2018  ...

PLA Use of "100 genes or more." It's baaaack!

›
 For several years, there seemed to be a PLA moratorium on the use of "or more" so you'd see the construction "Panel of 8...

CMS Issues New October PLA Codes, New October Clin Lab Fee Schedule CLFS. Essay on "Or More."

›
CMS has released the October 1, or fourth-quarter, Clin Lab Fee Schedule, CLFS.   The next one, on January 1, will be based on PAMA prices. ...

FDA Awards $1M for Approval Methods for AI Radiology Reports. Will AI Pathology Reports be Far Behind?

›
I've argued that the billion-dollar app in digital pathology will be an FDA-cleared app for draft report preparation.  (The pathologist ...
Sunday, October 4, 2026

Understanding Sparano via Understanding the "C Statistic"

›
The adjacent blog about the Oncotype test and Sparano's new IICM+ test, pivots almost every quantitative comparison on "C-statistic...

Is Sparano et al. Better than Oncotype DX? New Publication.

›
From time to time a test is published as "Better than Oncotype Dx," which has been around since about 2004. Some have even been ba...

Case Study: The Border Between Wellness Devices, Medical @Home Devices, and Coding

›
 What happens when a $299 wristband challenges a medical service built around much more expensive equipment?  In this fictional business sch...
Friday, October 2, 2026

What Cancer Payment Rewards, and What Gets Left Behind: Shah 2026 in JAMA Oncol.

›
 In a new article at JAMA Oncology Shah describes two treatments - one superior - and then reveals we pay $100,000 for the less useful thin...

When AI Beats Google: Agentic AI Searchs for Media about "14 Day Rule"

›
The "14 day rule" for CMS lab specimens is pretty obscure.  I asked Chat GPT to search the internet for media, op eds, etc, on 14 ...
Tuesday, September 29, 2026

CMS Releases Pricing Proposals for 110 New 2027 Lab Codes

›
 CMS has released its 110 proposals for new lab codes for 2027.  On this web page , scroll down for Agendas and Important Materials to find ...

MolDx: Final Gapfill Pricing for CY2027

›
The gapfill year has run its course for 17 codes. We saw proposed prices in May, final pries in September.  Five codes changed price (althou...

Digital Pathology Update: Signals from Leica, from CAP TODAY, from Mayo

›
 [AI generated, Chat GPT 5.6] [Links at bottom] ## Future of Digital Pathology: Signals from Leica, Mayo, and CAP TODAY Digital pathology’s ...

Date of Service Rule for Inpatients: Does It Conflict with Other Regulations?

›
The Medicare Date of Service rule defines "date of specimen collection" as the "date of service" - for inpatients, unles...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.